CME Group Inc. (NASDAQ:CME) has been given a consensus recommendation of “Buy” by the eleven research firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $138.38.

A number of research analysts have recently issued reports on CME shares. BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a report on Wednesday, September 27th. Barclays PLC lifted their price objective on shares of CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a report on Tuesday. Jefferies Group LLC reiterated a “buy” rating and set a $128.00 price objective on shares of CME Group in a report on Monday, July 10th. UBS AG reiterated a “buy” rating and set a $135.00 price objective (up from $134.00) on shares of CME Group in a report on Wednesday, September 6th. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and set a $127.00 price objective on shares of CME Group in a report on Friday, July 14th.

In related news, insider Hilda Harris Piell sold 1,350 shares of the business’s stock in a transaction dated Thursday, October 5th. The shares were sold at an average price of $138.00, for a total transaction of $186,300.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Chairman Terrence A. Duffy sold 21,815 shares of the business’s stock in a transaction dated Wednesday, August 2nd. The shares were sold at an average price of $123.89, for a total transaction of $2,702,660.35. Following the completion of the transaction, the chairman now owns 110,711 shares in the company, valued at $13,715,985.79. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 47,094 shares of company stock worth $5,896,940. 0.57% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Fiduciary Trust Co. purchased a new position in CME Group in the second quarter valued at about $105,000. Quadrant Capital Group LLC boosted its stake in CME Group by 13.6% in the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after acquiring an additional 113 shares during the last quarter. San Francisco Sentry Investment Group CA purchased a new position in CME Group in the second quarter valued at about $129,000. Whittier Trust Co. boosted its stake in CME Group by 2.6% in the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock valued at $133,000 after acquiring an additional 27 shares during the last quarter. Finally, People s United Financial Inc. boosted its stake in CME Group by 11.5% in the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after acquiring an additional 110 shares during the last quarter. Hedge funds and other institutional investors own 82.64% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://www.americanbankingnews.com/2017/10/12/cme-group-inc-cme-receives-average-recommendation-of-buy-from-analysts.html.

Shares of CME Group (NASDAQ CME) traded up 0.42% during trading on Thursday, reaching $137.77. 451,206 shares of the company were exchanged. The stock’s 50-day moving average is $131.65 and its 200-day moving average is $123.63. CME Group has a 52-week low of $98.95 and a 52-week high of $138.49. The firm has a market cap of $46.83 billion, a price-to-earnings ratio of 28.12 and a beta of 0.73.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.03. The firm had revenue of $925.00 million during the quarter, compared to analysts’ expectations of $931.05 million. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The business’s revenue was up 2.1% on a year-over-year basis. During the same period last year, the company earned $1.14 earnings per share. Equities research analysts predict that CME Group will post $4.81 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Monday, September 25th. Investors of record on Friday, September 8th were issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 1.92%. The ex-dividend date was Thursday, September 7th. CME Group’s dividend payout ratio (DPR) is presently 53.99%.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.